αTrop2/αCD3 bispecific protein engager-armed T cells (BATs) exhibit potent antitumor activity against nasopharyngeal carcinoma
Abstract Nasopharyngeal carcinoma (NPC) remains a highly aggressive malignancy with poor outcomes in advanced and recurrent disease. Although immune checkpoint inhibitors combined with chemotherapy improve survival, many patients still experience relapse or disease progression. Here, we developed a...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2026-05-01
|
| Seri Bilgileri: | Cancer Immunology, Immunotherapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s00262-026-04406-y |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|